TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05204732

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intonation training
Description: The participants will receive intonation training (1h/week) for four weeks, aiming for more gender congruent intonation patterns.
Study: NCT06674434

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobilization with Movement
Description: Mobilization with Movement (MWM) is a manual therapy technique that combines active, patient-directed movements with passive joint mobilization to treat tennis elbow. To find joint restrictions or dysfunctions, a comprehensive patient assessment is the first step in the process. While the patient was in a supine position with the elbow fully extended and the forearm pronated, the therapist applied a sustained lateral glide of the forearm and stabilized the distal portion of the arm. While the patient asked to make a fist, the therapist kept up the lateral glide. Each session included three sets of movement-based mobilizations, each with ten repetitions. The entire course of treatment consists of twelve sessions.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sustained Stretch
Description: The basic concept of stretching involves lengthening the tendon during a state of relaxation. To stretch the Extensor Carpi Radialis Brevis tendon, the following position should be adopted: the elbow should be extended, the forearm in a pronated position, the wrist flexed, and the wrist should also be ulnar deviated, based on the patient's comfort level. This position should be maintained for 30 to 45 seconds and repeated three times before and after exercises in each treatment session, with a 30-second rest period in between.
Study: NCT05204732

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham therapy + intonation training
Description: The participants will first receive four weeks of sham therapy (with no expected effect on speech), during which information on voice functioning, voice surgery, voice hygiene, and transgender health care will be provided. In addition, during sham therapy, active intervention will be given around nonverbal communication. After four weeks of sham therapy, for ethical reasons, subjects in this group will also receive four weeks of intonation training (aiming for more gender congruent intonation patterns).
Study: NCT06674590

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation
Description: PNF of 30 minutes duration will given in a single session. Pelvic anterior elevation and posterior depression of the hemiplegic side. rhythmic initiation slow reversal agonistic reversals Pelvic anterior depression and posterior elevation of the hemiplegic side. The first diagonal (D1): Flexion and extension The second diagonal (D2): Flexion and extension 4 session per week
Study: NCT05041530

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: REBUILD Bioabsorbable
Description: REBUILD is an investigational medical device designed to be used with third-party suture to distribute suture tension in abdominal wall closures.
Study: NCT05030376

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: intraileal infusion
Description: intraileal glucose or intraileal saline infusion

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: intraileal infusion
Description: intraileal glucose or intraileal saline infusion
Study: NCT05037370

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wave-Front Optimized (WFO) ablation vs Topography-guided (TG) ablation
Description: Patient will undergo PRK or LASIK using WFO ablation in one eye and TG ablation on contralateral eye

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wave-Front Optimized (WFO) ablation vs Topography-guided (TG) ablation
Description: Patient will undergo PRK or LASIK using WFO ablation in one eye and TG ablation on contralateral eye
Study: NCT06240780

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Activated Incrediwear Products
Description: Activated Incrediwear products incorporates semiconductor elements within the fabric that releases negative ions when stimulated by body heat. The negative ions activate cellular vibrations that increase blood flow and circulation.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Activated Incrediwear Products
Description: Activated Incrediwear products incorporates semiconductor elements within the fabric that releases negative ions when stimulated by body heat. The negative ions activate cellular vibrations that increase blood flow and circulation.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sham Incrediwear Products
Description: Simple fabric Incrediwear products that do not include the semiconductor elements within the fabric.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sham Incrediwear Products
Description: Simple fabric Incrediwear products that do not include the semiconductor elements within the fabric.
Study: NCT06223035

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Participants will take part in a VO2max test. This will include a graded exercise test (GXT) on a motorized treadmill while wearing a one-way, non-rebreathing valve and nose clip that allows for the evaluation of all expired air. Specifically, we will incorporate the Ellestad Protocol. The Ellestad Protocol is divided into 8 phases which gradually increases in speed and incline throughout the test. The VO2max test will continue until the participant reaches volitional fatigue defined by reaching a rate of perceived exertion (RPE) greater than 19 (using the Borg RPE Scale), OR a respiratory exchange ratio (RER) reaching above 1.1, OR a participant choosing to cease exercise for any reason.
Study: NCT05901792

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Games
Description: Six different Nintendo Wii Fit Plus games will be employed for six weeks, three days a week, for a total of 18 sessions ranging from 40 to 60 minutes. The games will be chosen from those that emphasize shifting the body's center of gravity. In addition, participants will be given basic correction exercises (derotation, deflexion, basic tension, and lateral flexion 3\*3) at the beginning of the study and instructed to practice them at home for six weeks.

Intervention type: OTHER
Group type: OTHER
Intervention: Waiting List
Description: As the control group, the cases on the waiting list will be evaluated. The control group will be given basic elements of corrective exercises (derotation, deflexion, basic tension, and lateral flexion 3\*3) at the start of the study and instructed to practice at home for six weeks.
Study: NCT05741411

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: RPM-assisted specialist access
Description: Participants will be prompted to report current symptoms and activity once a day via remote patient monitoring chat technology for up to 28 days following injury. Patients with either escalating or plateauing symptoms will be flagged, with an electronic alert sent via the electronic health record to a nurse navigator. The nurse navigator will have access to the symptom data and facilitate scheduling an in person or telehealth specialist visit as indicated. Symptoms will continue to be monitored through the 28-day acute study period with additional clinical visits occurring according to clinical need.
Study: NCT05893043

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSBR-1290
Description: Participants will receive GSBR-1290 oral capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSBR-1290
Description: Participants will receive GSBR-1290 oral capsules.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will receive matching placebo oral capsules.
Study: NCT04763291

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Juice Plus+ Fruit, Vegetable and Berry blends
Description: Encapsulated juice powder concentrate derived from 36 dried fruits, vegetables and berries.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Juice Plus+ Fruit, Vegetable and Berry blends
Description: Encapsulated juice powder concentrate derived from 36 dried fruits, vegetables and berries.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Juice Plus+ Omega blend
Description: Encapsulated plant-based fatty acid supplement.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Juice Plus+ Omega blend
Description: Encapsulated plant-based fatty acid supplement.
Study: NCT05755191

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NEU-411
Description: Oral Doses

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral Doses
Study: NCT05037903

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Description: Cognitive and behavioral interventions aimed at increasing behavioral activation, and reducing procrastination and inattentive symptoms.
Study: NCT05049525

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Itraconazole 400 mg/day and terbinafine 500 mg/day administered orally.
Description: Itraconazole capsules of 100 mg, antifungal agent. Terbinafine tablets 250 mg (as terbinafine hydrochloride), antifungal agent.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Itraconazole's matching placebo 400 mg/day and terbinafine's matching placebo 500 mg/day administered orally.
Description: Matching placebo of itraconazole capsules of 100 mg, antifungal agent. Matching placebo of terbinafine tablets 250 mg, antifungal agent.
Study: NCT06674590

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Motor Relearning Program
Description: Motor Relearning Programme (MRP) This is a task-oriented approach to help the control of movement, focusing on the relearning of daily activities.
Study: NCT05585164

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Engage & Connect (E&C)
Description: Engage \& Connect, is a remotely-delivered extension of Engage psychotherapy. It is aimed to increase engagement in rewarding social activities and in turn, reduce postpartum depression. In each session, the therapist will work with the patient to develop action plans to pursue rewarding social activities of their choice with the goal of reducing social isolation.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Symptom Review and Psychoeducation (SRP)
Description: SPR is a remotely-delivered intervention aimed to increase knowledge of postpartum depression and monitor mental health changes. In each session, the therapist will review the participant's symptoms and discuss information related to postpartum depression and changes after birth.
Study: NCT06675851

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: WELLBUTRIN SR (Bupropion HCI) Sustained-Release Tablets, 150 mg; GlaxoSmithKline
Description: Bupropion 150 mg daily after baseline PET/MRI or MRI/MRS over 6-8 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cipralex (escitalopram)
Description: Escitalopram 10 mg daily after baseline PET/MRI or MRI/MRS over 6-8 weeks
Study: NCT06681012

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gelsectan®
Description: Oral capsules are to be taken twice a day for 2 months (two capsules in the morning before breakfast and two capsules in the evening before dinner during the first 4 weeks of treatment; one capsule in the morning and one in the evening during the following 4 weeks of treatment).
Study: NCT04990882

Intervention type: OTHER
Intervention: Interpretation of FAPI-PET/CT scans
Description: Each observer's Group will be asked to review FAPI-PET/CT scans of patients with representative cancer types.

Intervention type: OTHER
Intervention: Interpretation of FAPI-PET/CT scans
Description: Each observer's Group will be asked to review FAPI-PET/CT scans of patients with representative cancer types.
Study: NCT05778760

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Retinol
Description: Topical retinol (0.5%) applied to the face

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Adapinoid
Description: Topical Adapinoid (0.5%) applied to the face
Study: NCT05659680

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WiSE-CRT
Description: Participants undergo pre-procedural CT, implantation of the WiSE-CRT system targeting the left bundle branch area, and post procedural non-invasive electro-anatomical mapping using electrocardiographic imaging and haemodynamic assessment.
Study: NCT04990882

Intervention type: OTHER
Intervention: Interpretation of FAPI-PET/CT scans
Description: Each observer's Group will be asked to review FAPI-PET/CT scans of patients with representative cancer types.
Study: NCT06278961

Intervention type: OTHER
Intervention: Observational
Description: Observation of movement patterns through video recordings and neurodevelopmental battery of assessments.

Intervention type: OTHER
Intervention: Observational
Description: Observation of movement patterns through video recordings and neurodevelopmental battery of assessments.

Intervention type: OTHER
Intervention: Observational
Description: Observation of movement patterns through video recordings and neurodevelopmental battery of assessments.

Intervention type: OTHER
Intervention: Observational
Description: Observation of movement patterns through video recordings and neurodevelopmental battery of assessments.

Intervention type: OTHER
Intervention: Observational
Description: Observation of movement patterns through video recordings and neurodevelopmental battery of assessments.

Intervention type: OTHER
Intervention: Observational
Description: Observation of movement patterns through video recordings and neurodevelopmental battery of assessments.
Study: NCT06206044

Intervention type: DRUG
Intervention: Intrathecal 1.6 ml 0.75% bupivacaine in 8.25% dextrose combined with 15 mcg fentanyl and 150 mcg preservative-free morphine
Description: Patients will receive standard intrathecal medications for urgent and scheduled cesarean delivery at the study site. All study subjects will receive bupivacaine, fentanyl, and morphine.
Study: NCT05365867

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iCAN Group
Description: See description in iCAN study arm.
Study: NCT05870293

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: nurse coaching
Description: 2 sessions of nurse coaching including the Walt Disney method will be applied to the participants.
Study: NCT04855136

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BB2121
Description: CAR T Cell Therapy

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BB2121
Description: CAR T Cell Therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-220
Description: Cereblon (CRBN) E3 ligase modulatory compound (CELMoD)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986405
Description: gamma secretase inhibitor (GSI)
Study: NCT05705414

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valine
Description: A medical food intended for use under medical supervision

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valine
Description: A medical food intended for use under medical supervision

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EEA
Description: A medical food intended for use under medical supervision

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EEA
Description: A medical food intended for use under medical supervision
Study: NCT05467800

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Canakinumab
Description: Canakinumab administered as a subcutaneous injection on day 1 of a 21 day cycle for a core study period of 8 cycles.
Study: NCT05903495

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Deep Brain Stimulation
Description: randomized, sham-controlled, partial crossover study investigating DBS, targeting the nucleus accumbens (NAc) and ventral internal capsule (VC), for participants with severe, treatment refractory OUD.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation
Description: randomized, sham-controlled, partial crossover study investigating DBS, targeting the nucleus accumbens (NAc) and ventral internal capsule (VC), for participants with severe, treatment refractory OUD.
Study: NCT05950958

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multimodal therapy for prevention of delirium
Description: Multimodal therapy for prevention of delirium
Study: NCT06160908

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NirsCure
Description: True near-infrared light； Once a day, once for 30 minutes, 6 times a week

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham NirsCure
Description: Non near-infrared light irradiation；only the equipment appearance is consistent with the test device；Once a day, once for 30 minutes, 6 times a week

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NirsCure
Description: True near-infrared light； Once a day, once for 30 minutes, 6 times a week
Study: NCT05539716

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PAP Therapy
Description: Auto-PAP device (ResMed AirsenseTM Autoset) with a heated humidifier will be provided along with an appropriate mask and connecting hose for nightly use

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Counseling Intervention
Description: Lifestyle intervention will include counseling on (a) education on nutrition and exercise; and (b) behavioral support for identifying lifestyle change strategies and problem-solving barriers to improve the regularity and duration of sleep. This will be conducted using brochures on weight loss and sleep hygiene

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Counseling Intervention
Description: Lifestyle intervention will include counseling on (a) education on nutrition and exercise; and (b) behavioral support for identifying lifestyle change strategies and problem-solving barriers to improve the regularity and duration of sleep. This will be conducted using brochures on weight loss and sleep hygiene
Study: NCT05558124

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vyxeos
Description: Fixed dose of Vyxeos (44 mg/m2 daunorubicin and 100 mg/m2 cytarabine) (Day 1, 3, and 5) in combination with various dose schedules of Gemtuzumab Ozogamicin (GO)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemtuzumab Ozogamicin
Description: Participants will be treated at the following dose levels:~Dose Level 1 - Gemtuzumab Ozogamicin will administered 3mg/m2 on Day 1 Dose Level 2 - Gemtuzumab Ozogamicin will administered 3mg/m2 on Day 1 and 4 Dose Level 3 - Gemtuzumab Ozogamicin will administered 3mg/m2 on Day 1, 4, 7
Study: NCT06628869

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Fructanase
Description: Participants will consume one capsule containing 400 INU inulinase (325 mg, includes maltodextrin) with a mixture of oatmeal (40 grams) and inulin (25 grams). Participants will be directed to consume the capsule after two spoonfuls of oatmeal. The fructanase was obtained from Aspergillus tubingensis.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin placebo
Description: Participants will consume one capsule containing 300 mg maltodextrin with a mixture of oatmeal (40 grams) and inulin (25 grams). Participants will be directed to consume the capsule after two spoonfuls of oatmeal. The maltodextrin was obtained from tapioca.
Study: NCT06628908

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Suzetrigine
Description: Tablets for oral administration.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pregabalin
Description: Capsules for oral administration.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (matched to SUZ)
Description: Placebo matched to SUZ for oral administration.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo (matched to SUZ)
Description: Placebo matched to SUZ for oral administration.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (matched to Pregabalin)
Description: Placebo matched to Pregabalin for oral administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (matched to Pregabalin)
Description: Placebo matched to Pregabalin for oral administration.
Study: NCT05225337

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Time restricted feeding (TRF)
Description: 8-h eating window Ad libitum food intake from 12-8 pm every day Fasting from 8-12 pm every day (16-h fast)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Daily calorie restriction
Description: 25% energy restriction every day Diet counseling provided
Study: NCT04966741

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Setmelanotide
Description: SC injection once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Setmelanotide
Description: SC injection once daily.
Study: NCT06399198

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Free gingival graft
Description: After adequate local anesthesia is achieved, a horizontal incision will be placed at mucogingival junction level to prepare the recipient bed. A split-thickness flap will be raised without disturbing the periosteum. A free gingival graft will be obtained from the palate. The graft will be shaped and sutured to the recipient surface.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Free gingival graft
Description: After adequate local anesthesia is achieved, a horizontal incision will be placed at mucogingival junction level to prepare the recipient bed. A split-thickness flap will be raised without disturbing the periosteum. A free gingival graft will be obtained from the palate. The graft will be shaped and sutured to the recipient surface.
Study: NCT04967612

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual implantation
Description: Temporary placement of virtual optical lens in the crystalline lens plane.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual implantation
Description: Temporary placement of virtual optical lens in the crystalline lens plane.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual implantation
Description: Temporary placement of virtual optical lens in the crystalline lens plane.
Study: NCT05366075

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention 1 (simple exercise program)
Description: Up to four sessions per day (total duration 20-30 minutes/day). Performed at the hospital on all weekdays from baseline until hospital discharge (around 1 week). At discharge, the participants will be encouraged to continue with the exercise program at home.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention 2 (comprehensive exercise program)
Description: Two daily sessions (morning and afternoon) of 20 minutes' duration each. Performed at the hospital on all weekdays from baseline until hospital discharge (around 1 week).